HomeOpen Access NewsInfectious Diseases

Infectious Diseases

Collaboration is crucial for future pandemic preparedness

Pandemic preparedness: A new report has sounded the alarm on the urgent need to address global disparities and foster interdisciplinary cooperation to effectively prepare for and respond to future pandemics.

Canada: Infection & immunity focus

The Canadian Institutes of Health Research, part of the Government of Canada, has an Institute of Infection and Immunity. Here, we gain a flavour of what they do.

COVID-19 in Africa: Where are we?

Open Access Government caught up with Dr Mary Stephen, Public Health Expert at the World Health Organization African Region, provides an update on the COVID-19 outbreak in Africa.

New ‘superfungus’ emerges in Brazil during pandemic

Exhausted medical staff in Brazil have enough to deal with when it comes to COVID-19 - now, a new 'superfungus' has evolved beyond drug treatment.

PCR Biosystems: Scaling up the production of critical reagents in a crisis

Here, we interview Alex Wilson, Co-founder of specialist reagent company PCR Biosystems, discussing how their expertise in enzyme development and large-scale production has been successfully applied to COVID-19 testing solutions around the world.

Impact of climate change on vectors & vector-borne diseases

Florence Fouque from the World Health Organization describes the unpredictability and risks of health systems disruptions due to the impact of climate change on vectors & vector-borne diseases.

Study says international travel increases antimicrobial resistance

A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".

Scientists say vaccines less effective against Delta variant

According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.

Study finds fatigue is more common in mild COVID cases

Scientists have found that neurological symptoms, like fatigue, are more common in people with mild COVID cases - as opposed to only in severe COVID cases.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

Oliver R Tambo Africa Research Chair at SACIDS Foundation for One Health

Named after a freedom fighter who spoke up for science and tech, a group of African and international research funders under the OR Tambo Africa Research Chairs Initiative announced Prof Gerald Misinzo and his institution Sokoine University of Agriculture as one of the initiative’s first ten individual research chair holders and host institutions.

Schools need Gov approved cleaning procedures & clear safety standards

Graham Mimms, Hygiene Aviation Expert and co-founder of Safe Surface Sensor, explains why the only way to stop a future health crisis is to ensure we have strict hygiene policies in place.

COVID-19 & the urgent case for a greater focus on One Health

Frances Goodrum, Head of External Affairs, Brooke Action for Working Horses and Donkeys, turns our attention to COVID-19 and the urgent case for a greater focus on One Health.

Safe NHS environments: For patient, clinician & support worker

Kate Edwards, Director at Intelligent Infection Control Services Limited, LumiBio, underlines the importance of creating safe environments for the patient, clinician & support worker in the NHS.

Dogs can sniff out coronavirus with 96% accuracy

According to a new study, led by the University of Pennsylvania, specially trained detection dogs can sniff out positive COVID-19 samples with 96% accuracy.

Rapid COVID-19 test kit receives scientific seal of approval

Researchers from Simon Fraser University have approved a faster, cheaper COVID-19 test kit that could expand more widespread rapid testing.

COVID patients have antibodies “11 months after first symptoms”

Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders